Massimo Del Fabbro | Translational Research | Breakthrough Research Award

Published on by Health Scientists

Breakthrough Research Award

Massimo Del Fabbro
Università degli Studi di Milano, Italy
Massimo Del Fabbro
Researcher Massimo Del Fabbro
Affiliation Università degli Studi di Milano
Country Italy
Scopus ID 7004132028
Documents 584
Citations 15791
h-index 66
Subject Area Public Health
Event Health Scientists Awards
ORCID 0000-0001-7144-0984

The advancement of public health and healthcare sciences is strongly connected to the contributions of researchers whose scholarly activities support clinical innovation, evidence-based practice, and interdisciplinary scientific development. Massimo Del Fabbro, affiliated with Università degli Studi di Milano in Italy, has established a substantial academic presence through publications, citations, and collaborative healthcare investigations.[1] This article presents a structured overview of the academic profile, research contributions, and scholarly impact associated with the Breakthrough Research Award under the Health Scientists Awards initiative.[2]

Abstract

This article summarizes the scholarly achievements and academic influence of Massimo Del Fabbro in the field of public health and healthcare sciences. The overview examines publication productivity, citation indicators, institutional affiliations, and interdisciplinary scientific contributions associated with healthcare research and clinical advancement. The article additionally evaluates the relevance of these academic accomplishments within the framework of the Breakthrough Research Award presented by the Health Scientists Awards platform.[1][2]

Keywords

  • Public Health
  • Healthcare Sciences
  • Clinical Research
  • Epidemiology
  • Healthcare Innovation
  • Academic Recognition
  • Università degli Studi di Milano

Introduction

Research in public health and healthcare sciences contributes significantly to the development of clinical methodologies, healthcare management systems, and evidence-based medical practices. Recognition programs within the scientific community often emphasize the importance of sustained publication activity, citation influence, and interdisciplinary collaboration in advancing healthcare knowledge.[2] Massimo Del Fabbro has developed an extensive scholarly profile through contributions to healthcare and public health literature indexed within major academic databases. The researcher’s publication portfolio and citation performance indicate sustained scientific engagement and continued influence within healthcare-related disciplines.[1]

Research Profile

Massimo Del Fabbro is affiliated with Università degli Studi di Milano in Italy and has contributed extensively to scientific investigations related to healthcare sciences and public health. The Scopus author profile associated with Author ID 7004132028 reports 584 indexed documents, reflecting substantial research productivity and long-term academic participation.[1] The academic profile further demonstrates scholarly visibility through 15,791 citations and an h-index of 66. These indicators suggest broad dissemination of research findings and continuing recognition within the international scientific community.[1]

  • Institutional Affiliation: Università degli Studi di Milano
  • Primary Subject Area: Public Health
  • Indexed Publications: 584
  • Citation Count: 15,791
  • h-index: 66

Research Contributions

The scientific contributions associated with Massimo Del Fabbro involve clinical investigations, healthcare evaluation methodologies, epidemiological analysis, and evidence-based healthcare practices. These contributions support the advancement of medical research and provide relevant insights for healthcare professionals and policy-oriented scientific studies.[3] The researcher’s interdisciplinary collaborations and publication activities demonstrate active participation in scientific communication networks and international healthcare research initiatives.[4]

  • Clinical and healthcare research investigations
  • Public health and epidemiological analysis
  • Scientific collaboration in healthcare sciences
  • Evidence-based healthcare methodologies
  • Academic dissemination through indexed journals

Publications

The publication portfolio associated with Massimo Del Fabbro includes numerous articles indexed in internationally recognized academic databases and healthcare journals. The breadth of publications demonstrates consistent scientific activity and participation in interdisciplinary healthcare research initiatives.[1]

  1. Peer-reviewed scientific articles related to healthcare and public health sciences.
  2. Research publications indexed in Scopus and associated healthcare databases.
  3. Collaborative studies addressing healthcare innovation and clinical methodologies.
  4. Evidence-based publications supporting healthcare improvement and scientific advancement.

Research Impact

The citation metrics associated with Massimo Del Fabbro indicate substantial academic visibility and scientific influence within healthcare sciences and public health research. Citation-based indicators are commonly used to evaluate the dissemination and scholarly relevance of scientific publications across academic communities.[1] The combination of publication productivity, interdisciplinary research participation, and citation performance contributes to the researcher’s academic standing and supports continuing engagement in international scientific discourse related to healthcare innovation and evidence-based medicine.[3]

Award Suitability

The Breakthrough Research Award recognizes researchers who demonstrate sustained scientific productivity, interdisciplinary impact, and measurable scholarly influence. Based on publication activity, citation metrics, and healthcare-related research engagement, Massimo Del Fabbro demonstrates several characteristics commonly associated with scientific recognition initiatives.[2] The combination of extensive academic publications, international research visibility, and measurable citation influence supports the relevance of this recognition within the Health Scientists Awards framework and broader scientific community.[1]

Conclusion

Massimo Del Fabbro has contributed significantly to healthcare sciences and public health research through scientific publications, interdisciplinary collaboration, and evidence-based healthcare investigations. The researcher’s publication record, citation performance, and international academic visibility demonstrate continued engagement with scientific advancement and healthcare innovation. This article provides a structured academic overview associated with the Breakthrough Research Award and highlights scholarly contributions within healthcare and public health sciences.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Massimo Del Fabbro, Author ID 7004132028. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7004132028
  2. Health Scientists Awards. (n.d.). Breakthrough Research Award and Health Scientists Awards overview.
    Health Scientists Awards
  3. ORCID. (n.d.). ORCID profile of Massimo Del Fabbro.
    https://orcid.org/0000-0001-7144-0984
  4. Google Scholar. (n.d.). Google Scholar citation profile for Massimo Del Fabbro.
    https://scholar.google.com/citations?user=iaV7iGwAAAAJ&hl=en&oi=ao

  5. Capelli, M., Zuffetti, F., Del Fabbro, M., & Testori, T. Immediate rehabilitation of the completely edentulous jaw with fixed prostheses supported by either upright or tilted implants: a multicenter clinical study.

    https://pubmed.ncbi.nlm.nih.gov/17929526/

Gauthami Pulivendala | Translational Research | Young Researcher Award

Published on by Health Scientists

Dr. Gauthami Pulivendala | Translational Research | Young Researcher Award

Postdoc Associate | University of Miami | United States

Dr. Gauthami Pulivendala is a researcher at Sylvester Comprehensive Cancer Center, specializing in cancer biology, fibrosis, and molecular signaling pathways. Her work focuses on understanding mechanisms such as the ChREBPα-mediated regulation of hepatic stellate cell activation and its role in liver fibrosis, contributing to advancements in translational oncology. With 11 publications, 318 citations, and an h-index of 9, she demonstrates strong research impact and scientific productivity. Collaborating with an extensive network of co-authors, her research reflects interdisciplinary engagement across cancer biology and metabolic disease domains. Her contributions hold significant societal value by advancing knowledge in fibrosis and tumor microenvironment interactions, supporting the development of targeted therapies, and improving clinical strategies for cancer and liver-related diseases, thereby contributing to global health innovation and patient care outcomes.

Citation Metrics (Scopus)

318
240
160
80
0

Citations

318

Documents

11

h-index

9

Citations

Documents

h-index

View Scopus Profile View Google Scholar Profile

Featured Publications


Inhalation of sustained release microparticles for the targeted treatment of respiratory diseases

– Drug Delivery and Translational Research, 2020 | Citations: 62

Hui Saan Tham | Translational Research | Research Excellence Award

Published on by Health Scientists

Dr. Hui Saan Tham | Translational Research | Research Excellence Award

Director | Han Neuro Acupuncture & Herbal Specialist | Malaysia

Dr. Hui Saan Tham is the Chief Physician at Han Neuro Acupuncture and Herbal Specialists, specializing in translational research that integrates acupuncture, herbal medicine, and advanced medical technologies. Their recent publication on an EfficientNet-based deep learning system for ultrasound assessment of neck disorders reflects a pioneering approach to combining artificial intelligence with clinical diagnostics. Working collaboratively with multidisciplinary teams, they contribute to the development of innovative, evidence-based healthcare solutions. Although at an emerging stage in terms of publication count and citation metrics, their work demonstrates strong potential for impact in integrative and precision medicine. Their contributions hold significant societal value by promoting accessible, non-invasive therapeutic strategies and enhancing diagnostic accuracy, particularly in neuromuscular conditions, thereby supporting improved patient outcomes and advancing global healthcare innovation.

View Google Scholar Profile

Featured Publication

Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award

Published on by Health Scientists

Prof. Pradeep Kumar Chand | Translational Research | Best Health Biotechnology Award 

Former Vice Chancellor | Utkal University | India

Prof. (Dr.) Pradeep Kumar Chand is a distinguished academician and researcher, currently serving as Chairperson of NAAC Peer Teams constituted by the National Assessment and Accreditation Council (Government of India) and formerly the Vice Chancellor of a State University. He earned his B.Sc. (Botany Hons.) and M.Sc. (Botany) with top distinctions and obtained his Ph.D. in Science from a reputed university in the United Kingdom, specializing in Plant Biotechnology and Genetic Engineering. With over 37 years of teaching and research experience, Prof. Chand’s pioneering contributions encompass plant tissue culture, genetic transformation, somatic hybridization, DNA fingerprinting, biogenic nanotechnology, and phytochemical analysis. He has guided numerous postgraduate research scholars, including several Ph.D. and M.Phil. awardees, and has authored numerous research papers in reputed international and national journals. His work in green nanotechnology and nano-onco-therapeutics has earned wide academic recognition. Prof. Chand has been honored with prestigious fellowships from organizations such as the DBT, DST, and INSA, and has served as a Biotechnology Overseas Associate under the Government of India’s Department of Biotechnology. His research collaborations with globally recognized institutions in Europe, Asia, and the United States highlight his international scientific engagement. Additionally, Prof. Chand has held editorial and peer-review roles in several scientific journals, contributing significantly to advancing research standards in biotechnology and plant sciences both nationally and internationally. He has 2333 citations from 81 documents with an h-index of 27.

Profiles: Google Scholar | Scopus

Featured Publications

1. Genetically transformed root extracts of medicinal plant Sida acuta Burm.f. attenuate hyperglycemic effects in induced diabetic rats. (2025). Plant Cell, Tissue and Organ Culture.

2. Validation of PCR amplicon-based directed amplified minisatellite DNA (DAMD) markers for analysis of population structure and fruit trait association of promising Indian mangoes. (2025). Genetic Resources and Crop Evolution.

3. Hexavalent chromium bioaccumulation mediated enhancement of pyrethrin production in African marigold (Tagetes erecta L.): a promising plant for phytoremediation. (2023). Acta Physiologiae Plantarum.

4. Silver nanocrystals bio-fabricated using Rhizobium rhizogenes-transformed in vitro root extracts demonstrate health proactive properties. (2022). Bionanoscience.

5. Anthropogenic interventions regulate forest structure and carbon stock in transitional dry forests of Similipal Biosphere Reserve, India. (2022). Ecoscience.

Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Published on by Health Scientists

Dr. Miguel Garcia-Gonzalez | Translational Research | Innovative Research Award

Research group leader | FIDIS/IDIS | Spain

Dr. Miguel García González is a distinguished biomedical researcher and Group Leader at the Instituto de Investigación Sanitaria de Santiago (IDIS/CHUS) in Spain, specializing in Molecular Genetics and Developmental Biology of Kidney Diseases. He earned his Ph.D. in Molecular Biology from the University of Santiago de Compostela, where he developed a strong foundation in genetics, molecular mechanisms, and translational nephrology. His research focuses on understanding the genetic and molecular bases of polycystic kidney disease (PKD) and related hereditary disorders, integrating genomic, cellular, and developmental biology approaches to identify novel therapeutic targets. Dr. García González has authored more than 40 peer-reviewed publications in high-impact journals such as Nature Medicine, PNAS, Kidney International, and Human Molecular Genetics, contributing significantly to the field’s understanding of renal pathophysiology. His work has received numerous national and international research grants and awards, recognizing his excellence in scientific innovation and mentorship. He actively participates in editorial and peer-review roles for several leading journals in nephrology and molecular biology, further influencing the direction of biomedical research. In addition to his research contributions, Dr. García González is deeply committed to training young scientists, supervising doctoral and postdoctoral researchers, and fostering interdisciplinary collaboration across clinical and molecular domains. His pioneering work continues to advance precision medicine approaches in nephrology, bridging basic science discoveries with clinical applications aimed at improving outcomes for patients with genetic kidney diseases. He has 1913 citations from 50 documents with an h-index of 20.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. A comparative proteomic, transcriptomic and glycomic analysis of extracellular vesicle isolation techniques highlights ExoGAG efficiency for a more complete identification of breast milk molecular signaling pathways. (2025). Cell Communication and Signaling.

2. Therapeutic opportunities in polycystic kidney and liver disease through extracellular matrix dynamics. (2025). Biochemical Pharmacology.

3. Characterization of recurrent UMOD variants (p.C255Y and p.Q316P) in a Galician cohort: Genotype–phenotype correlation and clinical implications. (2025). Nefrología.

4. Characterization of the functional component in human milk and identification of the molecular mechanisms undergoing prematurity. (2025). Clinical Nutrition.

5. HNF1B transcription factor: Key regulator in renal physiology and pathogenesis. (2025).